The AMR Narrative

Facebook X-twitter Instagram Linkedin Youtube
Menu

Tweetchat: Raising our voices for AMR and Rare Diseases

Tweetchat: Raising our voices for AMR and Rare Diseases

Info

 

 

In partnership with the Center for Infectious Disease Research and Policy – Antimicrobial Stewardship (CIDRAP-ASP)
we invite you to join us on the 28th of February 2023 to discuss the impact of Antimicrobial Resistance on Rare Diseases.

Joining Details

  • Moderator: Francesca Chiara (@CIDRAP) and Vanessa Carter (@theAMRnarrative)
  • Date: 28 February 2023
  • Where: Twitter
  • Time: 4 pm – 5 pm GMT
  • Hashtag: #theAMRnarrative

How to participate:
Join us for a 60-minute Twitter chat with our panel experts. All stakeholders are welcome.

Start your answers with T1, T2, T3, T4, or CT for transcript purposes.
Answer only after the moderator prompts. Questions will be prompted every 10 minutes but keep answers coming using the relevant T and number. Both panel experts and the public are encouraged to answer.
Use the #theAMRnarrative hashtag in all your tweets so that you are visible to others in the chat and captured on the transcript.

 

Read more about the event on the CIDRAP website here.

Summary

Individuals with underlying diseases are more susceptible to developing dangerous and potentially life-threatening AMR infections.

For instance, patients with cystic fibrosis are prone to developing chronic upper respiratory tract infections because of the thick mucus that is secreted in the lungs as part of the disease process. Bacteria, including those that are drug-resistant, are more likely to become trapped within this mucus, causing an infection that could be difficult to treat with currently available medicines. Read our patients’ stories here (link).

Additional rare diseases that can be impacted by AMR include Osteomyelitis, Microatia, Thymic Carcinoma and Actinomycosis as well as conditions like craniofacial anomalies, which rely on continuous surgical interventions where antibiotics are prescribed to reduce and manage infections.

Various interventions including Antimicrobial Stewardship, education, and infection control (e.g. hand hygiene), as well as novel treatments like phage therapy, are being utilised to tackle AMR. The WHO describes “Antimicrobial stewardship” as interventions designed to promote the optimal use of antibiotic agents, including drug choice, dosing, route, and duration of administration. It would be important to understand how these can improve patient outcomes in the rare disease community.

Join us for a 60-minute Twitter chat to share your views about the impact of antimicrobial resistance and rare diseases. The chat is primarily for patients, carers, charities, members of the public, and related stakeholders, but we welcome everyone’s views.

 

Questions:
T1: What is AMR and why could it be a problem for patients affected by rare diseases?
T2: Why are rare disease patients so badly affected by AMR infections?
T3: How might we reduce the incidence of infection or improve treatment options for rare disease patients in relation to AMR?
T4: What is antimicrobial stewardship and how can it support patients with rare diseases?
T5: What interventions do you think could reduce the risk of AMR in clinical settings (e.g. hospitals) for rare disease patients?
CT: Any thoughts you would like to add about the impact of AMR and rare diseases?

 

Info
Category: ,
Location: Twitter
Date: February 28, 2023
Duration: 1 Day

Andrea Hartley

Andrea has worked in health communications and campaigning for 3 decades. She is committed to fighting AMR through timely and appropriate communications globally,.

Andrea set up Skating Panda, the creative social and environmental impact consultancy, over a decade ago and drives its impact and growth. Focused on original and lasting public interest communications as well as issue strategy and advocacy, the Panda team has a track record of prompting tipping points in the status quo that drive better social and planetary outcomes.

Andrea’s combination of commercial marketing and development experience with deep issue knowledge have been sought by decision-makers at global summits, corporate and NGO board members, and have enabled her to set up multi-million fundraising platforms and push through policies that change and save lives. 

Andrea is Vice Chair of mothers2mothers, the world’s largest employer of women living with HIV, and a Board Director of Maymessy, a food poverty social enterprise.

A lifelong advocate for gender equality, she played a key role in establishing the UK’s Women’s Equality Party.

Esmita Charani

Professor Esmita Charani is a pharmacist and researcher investigating how we use antibiotics in different cultural and social contexts. She works with teams in the UK, India, and South Africa to develop research programmes investigating all aspects of antimicrobial resistance in human populations with a focus in hospital settings.

She has experience in communicating her research with patients and the public through various media including animations, blogs, and educational videos.